Loading ...
The study showedcan leadto significant neurological improvements in post stroke patients even at chronic late stages
The results indicatecan leadto significant neurological improvements in post stroke patients even at chronic late stages
Conclusions the results indicatecan leadto significant neurological improvements in post stroke patients even at chronic late stages
indicatedcan leadto significant neurological improvements in post - stroke patients ... even at chronic late stages
the results ... that hbotcan leadto significant neurological improvements in post stroke patients even at chronic late stages
Conclusions the results ... that hbotcan leadto significant neurological improvements in post stroke patients even at chronic late stages
that hbotcan leadto significant neurological improvements in post stroke patients even at chronic late stages
The clinical results indicatecan leadto significant neurological improvements in the post stroke patients ... even at chronic late stage
The clinical results indicatecan leadto significant neurological improvements in post stroke patients ... even at chronic late stage
to avoidinfluencingthe acute phase of post - stroke inflammation
These eventswill ultimately resultin spontaneous recurrent seizures in the chronic phase of the model
an extensive expansion of myeloid progenitorsresultsin hematopoietic failure during the acute phase of chronic myeloid leukemia25,26
peripheral afferent drivecontributesminimally to the behavioral sensitization during the chronic phase of an inflammatory injury
The genetic eventscausethe progression of chronic phase to blast crisis
This study showedcontributesto impaired postural control in the acute phase of stroke
These experimental datahave ledto the initiation of a multicenter clinical trial of bFGF in acute stroke patients
additional imagingcausesdelays in the initiation of treatment of patients with acute ischemic stroke
treatment with these inhibitorsleadsto durable therapeutic responses in chronic phase CML
compared to an internal focusdid ... resultin more automated movements in chronic stroke patients
signalscauseacute phase inflammatory responses to become chronic
Acquisition of additional genetic and/or epigenetic abnormalitiescausesthe progression of CML from chronic phase to blast phase
Background and purpose : Hemorrhagic transformation ( HT ... a complicationmay causeneurological deterioration in patients with acute ischemic stroke
doctorsmay ... causeacute phase due to RA patients
a 2-week long intravenous vinpocetine treatmentcan contributeeffectively to the redistribution of rCBF in chronic ischemic stroke patients
factorsinfluencingdefecation in patients with acute stroke
The virus also attacks peripheral blood mononuclear cellscausinghigher levels of immunological disorders in chronic patients
a physical activity questionnairespecifically designedfor ambulatory , chronic stroke patients
Use the nursing processto contributeto the care of clients with transient ischemic attack and stroke
an e19a2 BCRABL1 fusionleadingto a diagnosis of chronic phase CML
factorsmay influencefunctional gain of patients with chronic sequelae of stroke
a 2-week long intravenous vinpocetine treatmentcan contributeto the redistribution of rCBF in chronic ischemic stroke patients
Lecithin supplemented through a retarded release mechanismcausedclinical remission in a trial of patients with chronic UC
by a presumed paradoxical embolism(passive) caused bypatients with recurrent cryptogenic stroke
A carotid webmay contributeto recurrent ischemic stroke in patients
a presumed paradoxical embolism through a PFO who have failed conventional drug therapy(passive) caused bypatients with recurrent cryptogenic stroke
Preadmission use of benzodiazepines does not appearto ... influenceoutcomes in patients with acute ischaemic stroke
in better outcomesresultin better outcomes
to haematopoietic stem cell transplantationleadingto haematopoietic stem cell transplantation
to the inclusions of subjects without acute intracranial large artery occlusions [ 16,17ledto the inclusions of subjects without acute intracranial large artery occlusions [ 16,17
in modest decreases in impairment ... with functional improvement and improved QOLresultedin modest decreases in impairment ... with functional improvement and improved QOL
to inform you of your risk factors , as well as how to manage your risk of a second strokedesignedto inform you of your risk factors , as well as how to manage your risk of a second stroke
the increase of DLPFC and insular activation observed in patients with hemispheric stroke(passive) is caused bythe increase of DLPFC and insular activation observed in patients with hemispheric stroke
Follow - upresultsFollow - up
to antibiotic or to a brain infectioncan leadto antibiotic or to a brain infection
The European Stroke Scale ( ESS ) , which consists of 14 items selected for their specificity and their prognostic value(passive) was designedThe European Stroke Scale ( ESS ) , which consists of 14 items selected for their specificity and their prognostic value
to different treatmentwill leadto different treatment
The sample(passive) was composedThe sample
to automatically assign each user to specific games and difficulty levels that best suit the user 's cognitive needsis designedto automatically assign each user to specific games and difficulty levels that best suit the user 's cognitive needs
Suppurative cutaneous granulomata(passive) caused bySuppurative cutaneous granulomata
to improved functional outcomesleadsto improved functional outcomes
to heart failurecould leadto heart failure
to read out in two yearssetto read out in two years
the outcomemay influencethe outcome
in extensive knowledge and experience in patient managementresultingin extensive knowledge and experience in patient management
small pouches to bulge outward at weak points along the inner lining of your large intestine , or coloncausessmall pouches to bulge outward at weak points along the inner lining of your large intestine , or colon
in a marked reduction in risk of disabilitymay resultin a marked reduction in risk of disability
from an over - active immune systemresultingfrom an over - active immune system
to low but significant concentrations of peptideleadsto low but significant concentrations of peptide
One stem cell therapy , SB623(passive) is designedOne stem cell therapy , SB623
from persistent injury or individual factorscan resultfrom persistent injury or individual factors
to impairment of hematopoietic stem cell functionsleadsto impairment of hematopoietic stem cell functions
in functional recoveryresultedin functional recovery